IntelligenceOverview
NewsBriefingJournalismTesseract
ExposureReportsNeural WebPlayersGeopoliticsSignal Map
MarketsMarket SignalsPulse
Entity

Tenax Therapeutics

Tenax Therapeutics is a biopharmaceutical company that develops and commercializes therapies for cardiovascular diseases, including drugs for heart failure.

Why it’s in the news: It is in the news because its lead heart failure drug failed in a pivotal clinical trial.

Explore Tenax Therapeutics in the interactive graph

Latest on Tenax Therapeutics

  • STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study
  • 13F: Stonepine Capital Management Llc holds Tenax Therapeutics ($10M)

Connections

3 entities linked to Tenax Therapeutics across the news graph.

Also connected to (3)
Stonepine Capital Management LlcHeartSTAT
Open the interactive Neural Web →Intelligence Briefs